SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Cantor Fitzgerald Maintains Overweight on Rigel Pharmaceuticals, Lowers Price Target to $5

Cantor Fitzgerald maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Overweight and lowers the price target from $7 to $5.

Benzinga · -

Cantor Fitzgerald maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Overweight and lowers the price target from $7 to $5.